SCM
AURA icon

Suvretta Capital Management’s Aura Biosciences AURA Stock Holding History

Suvretta Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.2M Buy
7,206,217
+2,833,333
+65% +$20.3M 0.94% 30
2026
Q1 		$29.3M Hold
4,372,884
– – 0.75% 42
2025
Q4 		$23.8M Hold
4,372,884
– – 0.49% 52
2025
Q3 		$27M Hold
4,372,884
– – 0.69% 46
2025
Q2 		$27.4M Buy
4,372,884
+1,640,998
+60% +$9.6M 0.83% 37
2025
Q1 		$16M Buy
+2,731,886
New +$20.7M 0.59% 45

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Suvretta Capital Management's AURA Position: Q2 2026 in Review

Suvretta Capital Management increased its Aura Biosciences (AURA) stake by 65% in Q2 2026, buying an estimated $20.3M and bringing the position to 7,206,217 shares worth $51.2M. The position accounts for 0.94% of the portfolio, ranked #30.

Suvretta Capital Management first reported a position in AURA in Q1 2025 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Suvretta Capital Management held 7,206,217 shares of Aura Biosciences worth $51.2M as of Q2 2026.
  • Suvretta Capital Management bought 2,833,333 Aura Biosciences shares in Q2 2026, an estimated $20.3M.
  • Aura Biosciences made up 0.94% of Suvretta Capital Management's portfolio in Q2 2026, its #30 holding.
  • Suvretta Capital Management first reported a position in Aura Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.